This federal contract award, valued at $244,758.17, was issued by the Defense Health Agency to Immucor Inc., a manufacturer of goods, for the delivery of CAP R RS (3) 5 PLATE DOMESTIC. The contract is a firm fixed-price purchase order without a set-aside designation, with a period of performance through May 31, 2024. Immucor is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The company has a history...
This is a $4,970.47 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract provides Immucor's specialized reagents, blood analyzers, testing equipment, and related consumables to support blood typing, compatibility testing, antibody screening, and critical blood banking operations within federal health networks and military treatment centers. Immucor has a...
This is a $14,557.30 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a for-profit manufacturer of blood transfusion and transplantation diagnostics. The contract is for the delivery of unspecified in vitro diagnostic products, reagents, and test kits to support the blood typing, compatibility testing, and other blood banking operations required by the NIH Clinical Center. The contract does not have a set-aside...
Immucor Inc. has been awarded a $10,019.10 firm fixed price delivery order by the Department of the Air Force Air Combat Command to provide blood bank reagents in support of operations at Nellis Air Force Base in Nevada. The contract calls for Immucor to deliver reagents to enable blood typing, compatibility testing, antibody screening, and other critical blood banking functions through September 2024. No set-aside designation was applied to this procurement. Immucor currently holds multiple...
This is a $27,460.00 Firm Fixed Price purchase order awarded by the Defense Health Agency (DHA) to Immucor Inc., a manufacturer of in vitro diagnostic supplies. The contract is for the delivery of 111801 HB 301 MICROCUVETTS, which are specialized disposable equipment used in blood typing and compatibility testing procedures. Immucor is a prime vendor to federal agencies, including the Department of Veterans Affairs and the Indian Health Service, for a range of blood banking and...
This federal contract award to Immucor Inc. is a delivery order under the Invitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule contract. The award, valued at $63,723.76, is for the provision of 66813 -- CAPTURE R READY SCREEN products. Immucor is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The award was made by the Bureau of Medicine and Surgery, which is a Defense agency. Immucor has...
This is a $61,238.20 firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Immucor Inc. for the delivery of blood bank reagents. The contract has an ultimate completion date of October 1, 2027. Immucor, a manufacturer of in vitro diagnostic products for transfusion and transplantation testing, was awarded this sole source contract under FAR 13.106-1 based on its specialized capabilities and proprietary solutions. The contract is not associated with a federal...
This contract award is to Immucor Inc., a leading provider of automated instruments, reagents, and consumables for blood transfusion and transplantation compatibility testing. The award, valued at $6,462.79, is a firm fixed-price purchase order placed by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract does not have a set-aside designation. Immucor has previously provided a variety of goods and services related to in vitro diagnostics, reagents, test kits,...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
This is a federal contract award made by the National Institutes of Health (NIH) to Immucor Inc., a for-profit manufacturer of goods. The contract is a delivery order issued under Immucor's existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract for in vitro diagnostics, reagents, and testing supplies. The order is for $15,545.99 on a firm fixed price basis. Immucor has provided a variety of blood banking and transfusion diagnostic products and services to federal...